---
schema_version: "secwatch.filing_event.v1"
accession: "0001360604-23-000020"
form_type: "8-K"
ticker: "HR"
cik: "0001360604"
company_name: "Healthcare Realty Trust Inc"
filed_at: "2023-03-01T23:59:59+00:00"
generated_at: "2026-06-18T17:21:35.150838+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Healthcare Realty Trust Q4 net loss $35.8M; Normalized FFO $0.42 per share

## Summary
- Net loss attributable to common stockholders of $35.8M ($0.09 diluted EPS) for Q4 2022.
- Normalized FFO of $159.8M, or $0.42 per diluted share.
- Same store cash NOI (incl. JV share) increased 2.8% YoY in Q4; TTM growth 2.6%.
- Dividend of $0.31 per share payable March 21, 2023 to holders of record March 7.
- Closed on $1.25B in JV and asset sales in 2022 at 4.8% cap rate; additional $112.8M sales post-year-end.

## SEC filing metadata
- accession: 0001360604-23-000020
- form_type: 8-K
- ticker: HR
- cik: 0001360604
- company_name: Healthcare Realty Trust Inc
- filed_at: 2023-03-01T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1360604/000136060423000020/0001360604-23-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1360604/000136060423000020/hr-20230301.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001360604-23-000020
- JSON: https://secwatch.observer/filing/0001360604-23-000020.json
- Plain text: https://secwatch.observer/filing/0001360604-23-000020.txt

## Key facts
- Earnings Releases
  Healthcare Realty Trust Inc reported the fourth quarter ended December 31, 2022 results: net income $35.8 million, EPS $0.09 per diluted common share.
  - Period: the fourth quarter ended December 31, 2022
  - Net income: $35.8 million
  - EPS: $0.09 per diluted common share
  - Result: reported results
  source text: The Company reported net loss attributable to common stockholders of $35.8 million, or $0.09 per diluted common share, for the quarter ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1360604/000136060423000020/0001360604-23-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.